ユビキチンプロテアソーム機能障害は,ヒトの高縮性および膨張性心筋病変において起こります
Jaime M Predmore1, Ping Wang, Frank Davis
11150 W Medical Center Dr, 7301 MSRB III, Ann Arbor, MI 48109-0644, USA.
Circulation
|February 18, 2010
まとめ
ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome system) とは,ユビキチンプロテアソーム系 (Ubiquitin proteasome) とは
科学分野:
- 心血管生物学 心血管生物学
- 分子医学は分子医学である.
- 細胞生物学 細胞生物学
背景:
- ウビキチンプロテアソームシステム (UPS) は,タンパク質のホメオスタシスにとって極めて重要です.
- 人間の心臓機能不全におけるその役割は不明である.
- この研究では,心不全および高圧性心筋病 (HCM) のUPS機能を調査しています.
研究 の 目的:
- ヒトの心不全および高縮性心筋病変 (HCM) でのユビキチンプロテアソームシステムの機能を評価する.
主な方法:
- プロテアソームの機能は,ヒトの不全性ドナー心臓,エクスペラントされた不全性心臓,およびHCMミエクトミーサンプルで評価されました.
- UPSサブユニットのタンパク質分解活動とタンパク質含有量を測定しました.
- タンパク質の酸化レベルを調べました.
主要な成果:
- プロテアソームのプロテオリシス活動は,心臓の衰弱とHCMにおいて著しく低下しました.
- 機能不全の心臓では,機械的な放電後,活動が部分的に回復しました.
- 酸化的変異は,プロテアソームサブユニット含有量の変化なしに,心不全において増加した.
結論:
- プロテアゾームの活動は,ヒトの心筋疾患において低下しています.
- 欠陥のあるタンパク質の分解は,変異したプロテアソーム含有量ではなく,翻訳後の改変による可能性が高い.
- これは,心臓病におけるタンパク質蓄積の潜在的なメカニズムを強調しています.
関連する概念動画
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...